Skip to content
10-Q

Quarterly Report

Adhera Therapeutics, Inc.

0001493152-23-029594

← back to feed
Filed
Aug 21, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 18, 2023 4.22M sh
Shares Diluted Q2 2023 · Jun 30, 2023 98.54M sh
Shares Diluted Q2 2023 · Jun 30, 2023 3.26M sh
Shares Diluted Q2 2023 · Jun 30, 2022 1.14M sh
Shares Diluted Q2 2023 · Jun 30, 2022 2M sh
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$626K
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$690K
Stockholders Equity Q2 2023 · Jun 30, 2023 −$22.79M
Stockholders Equity Q2 2023 · Mar 31, 2023 −$23.09M
Stockholders Equity Q2 2023 · Dec 31, 2022 −$22.19M
Stockholders Equity Q2 2023 · Jun 30, 2022 −$20M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$25.5M
Stockholders Equity Q2 2023 · Dec 31, 2021 −$25.11M
Current Liabilities Q2 2023 · Jun 30, 2023 $22.87M
Current Liabilities Q2 2023 · Dec 31, 2022 $22.27M
Total Liabilities Q2 2023 · Jun 30, 2023 $22.87M
Total Liabilities Q2 2023 · Dec 31, 2022 $22.27M
Current Assets Q2 2023 · Jun 30, 2023 $82K
Current Assets Q2 2023 · Dec 31, 2022 $79K
Total Assets Q2 2023 · Jun 30, 2023 $82K
Total Assets Q2 2023 · Dec 31, 2022 $79K
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.01
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.20
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.27
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.27
Eps Basic Q2 2023 · Jun 30, 2023 $0.07
Eps Basic Q2 2023 · Jun 30, 2023 −$0.20
Eps Basic restated Q2 2023 · Jun 30, 2022 −$0.27
Eps Basic restated Q2 2023 · Jun 30, 2022 −$0.27
Net Income Q2 2023 · Jun 30, 2023 $271K
Net Income Q2 2023 · Jun 30, 2023 −$615K
Net Income Q2 2023 · Mar 31, 2023 −$886K
Net Income Q2 2023 · Jun 30, 2022 $99K
Net Income Q2 2023 · Jun 30, 2022 $25K
Net Income Q2 2023 · Mar 31, 2022 −$74K
Operating Income Q2 2023 · Jun 30, 2023 −$296K
Operating Income Q2 2023 · Jun 30, 2023 −$648K
Operating Income Q2 2023 · Jun 30, 2022 −$449K
Operating Income Q2 2023 · Jun 30, 2022 −$709K
Stock Repurchased Q2 2023 · Jun 30, 2022 $2K